Localized variation in ancestral admixture identifies pilocytic astrocytoma risk loci among Latino children

Background Pilocytic astrocytoma (PA) is the most common pediatric brain tumor. PA has at least a 50% higher incidence in populations of European ancestry compared to other ancestral groups, which may be due in part to genetic differences. Methods We first compared the global proportions of European, African, and Amerindian ancestries in 301 PA cases and 1185 controls of self-identified Latino ethnicity from the California Biobank. We then conducted admixture mapping analysis to assess PA risk with local ancestry. Results We found PA cases had a significantly higher proportion of global European ancestry than controls (case median = 0.55, control median = 0.51, P value = 3.5x10-3). Admixture mapping identified 13 SNPs in the 6q14.3 region (SNX14) contributing to risk, as well as three other peaks approaching significance on chromosomes 7, 10 and 13. Downstream fine mapping in these regions revealed several SNPs potentially contributing to childhood PA risk. Conclusions There is a significant difference in genomic ancestry associated with Latino PA risk and several genomic loci potentially mediating this risk.

[1]  L. McGuinness,et al.  Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic review , 2021, Neuro-oncology.

[2]  B. Browning,et al.  Fast two-stage phasing of large-scale sequence data. , 2021, American journal of human genetics.

[3]  Yajun Wang,et al.  Molecular Cloning and Functional Characterization of Three 5-HT Receptor Genes (HTR1B, HTR1E, and HTR1F) in Chickens , 2021, Genes.

[4]  J. Huguenard,et al.  NF1 mutation drives neuronal activity-dependent initiation of optic glioma , 2021, Nature.

[5]  Yun-wu Zhang,et al.  SNX14 deficiency-induced defective axonal mitochondrial transport in Purkinje cells underlies cerebellar ataxia and can be reversed by valproate , 2021, National science review.

[6]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. , 2020, Neuro-oncology.

[7]  H. Hakonarson,et al.  European genetic ancestry associated with risk of childhood ependymoma. , 2020, Neuro-oncology.

[8]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[9]  Mariella G. Filbin,et al.  Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells , 2019, Nature Communications.

[10]  J. Olson,et al.  Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics , 2019, International journal of cancer.

[11]  Kelsey E. Grinde,et al.  Genome-wide Significance Thresholds for Admixture Mapping Studies. , 2019, American journal of human genetics.

[12]  J. Barnholtz-Sloan,et al.  Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014 , 2018, JAMA oncology.

[13]  B. Browning,et al.  A one penny imputed genome from next generation reference panels , 2018, bioRxiv.

[14]  S. Eichmüller,et al.  Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E , 2018, Front. Immunol..

[15]  I. Smirnov,et al.  GWAS in childhood acute lymphoblastic leukemia reveals novel genetic associations at chromosomes 17q12 and 8q24.21 , 2018, Nature Communications.

[16]  Jill S Barnholtz-Sloan,et al.  Global incidence of malignant brain and other central nervous system tumors by histology, 2003–2007 , 2017, Neuro-oncology.

[17]  E. Hoving,et al.  Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas. , 2016, Critical reviews in oncology/hematology.

[18]  G. Breen,et al.  Quality control, imputation and analysis of genome-wide genotyping data from the Illumina HumanCoreExome microarray. , 2016, Briefings in functional genomics.

[19]  T. Bird.  Hereditary Ataxia Overview , 2016 .

[20]  M. Gautel,et al.  Vici syndrome: a review , 2016, Orphanet Journal of Rare Diseases.

[21]  George R. Bjorklund,et al.  Layer specific and general requirements for ERK/MAPK signaling in the developing neocortex , 2016, eLife.

[22]  David T. W. Jones,et al.  Pilocytic astrocytoma: pathology, molecular mechanisms and markers , 2015, Acta Neuropathologica.

[23]  C. Shayo,et al.  Dual Role of cAMP in the Transcriptional Regulation of Multidrug Resistance-Associated Protein 4 (MRP4) in Pancreatic Adenocarcinoma Cell Lines , 2015, PloS one.

[24]  S. Gabriel,et al.  Biallelic mutations in SNX14 cause a syndromic form of cerebellar atrophy and lysosome-autophagosome dysfunction , 2015, Nature Genetics.

[25]  Davide Heller,et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..

[26]  Carson C Chow,et al.  Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.

[27]  D. Altshuler,et al.  Simulation of Finnish population history, guided by empirical genetic data, to assess power of rare-variant tests in Finland. , 2014, American journal of human genetics.

[28]  W. Li,et al.  Novel function of the chromosome 7 open reading frame 41 gene to promote leukemic megakaryocyte differentiation by modulating TPA-induced signaling , 2014, Blood Cancer Journal.

[29]  C. Bustamante,et al.  RFMix: a discriminative modeling approach for rapid and robust local-ancestry inference. , 2013, American journal of human genetics.

[30]  Christopher A. Miller,et al.  Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma , 2013, Genome research.

[31]  A. Toker,et al.  NFAT promotes carcinoma invasive migration through glypican-6 , 2011, The Biochemical journal.

[32]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[33]  David H. Alexander,et al.  Fast model-based estimation of ancestry in unrelated individuals. , 2009, Genome research.

[34]  R. S. Johnson,et al.  Biology of HIF-1α , 2008, Cell Death and Differentiation.

[35]  C. Weiller,et al.  Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. , 2007, Neuropediatrics.

[36]  I. McKillop,et al.  The role of cAMP-MAPK signalling in the regulation of human hepatocellular carcinoma growth in vitro. , 1999, European journal of gastroenterology & hepatology.

[37]  D. Louis,et al.  PTEN mutations in gliomas and glioneuronal tumors , 1998, Oncogene.